(Press-News.org) Carrying out general health checks does not reduce deaths overall or from serious diseases like cancer and heart disease, according to Cochrane researchers. The researchers, who carried out a systematic review on the subject for The Cochrane Library, warn against offering general health checks as part of a public health programme.
In some countries, general health checks are offered as part of standard practice. General health checks are intended to reduce deaths and ill health by enabling early detection and treatment of disease. However, there are potential negative implications, for example diagnosis and treatment of conditions that might never have led to any symptoms of disease or shortened life.
The researchers based their findings on 14 trials involving 182,880 people. All trials divided participants into at least two groups: one where participants were invited to general health checks and another where they were not. The number of new diagnoses was generally poorly studied, but in one trial, health checks led to more diagnoses of all kinds. In another trial, people in the group invited to general health checks were more likely to be diagnosed with high blood pressure or high cholesterol, as might be expected. In three trials, large numbers of abnormalities were identified in the screened groups.
However, based on nine trials with a total of 11,940 deaths, the researchers found no difference between the number of deaths in the two groups in the long term, either overall or specifically due to cancer or heart disease. Other outcomes were poorly studied, but suggested that offering general health checks has no impact on hospital admissions, disability, worry, specialist referrals, additional visits to doctors or time off work.
"From the evidence we've seen, inviting patients to general health checks is unlikely to be beneficial," said lead researcher Lasse Krogsbøll of The Nordic Cochrane Centre in Copenhagen, Denmark. "One reason for this might be that doctors identify additional problems and take action when they see patients for other reasons."
"What we're not saying is that doctors should stop carrying out tests or offering treatment when they suspect there may be a problem. But we do think that public healthcare initiatives that are systematically offering general health checks should be resisted."
According to the review, new studies should be focused on the individual components of health checks and better targeting of conditions such as kidney disease and diabetes. They should be designed to further explore the harmful effects of general health checks, which are often ignored, producing misleading conclusions about the balance of benefits and harm. Another problem is that those people who attend health checks when invited may be different to those who do not. People who are at a high risk of serious illness may be less likely to attend.
###
Cochrane Review finds no benefit from routine health checks
2012-10-17
ELSE PRESS RELEASES FROM THIS DATE:
Cranberry juice now unlikely to prevent cystitis
2012-10-17
Cranberry juice is unlikely to prevent bladder and kidney infections, according to an updated systematic review published in The Cochrane Library. The authors analysed the most up-to-date evidence and concluded that any benefit, if present at all, is likely to be small and only for women with recurrent UTI.
Urinary tract infections (UTIs) affect the bladder, as in cystitis, and sometimes the kidneys. Cranberries and cranberry juice have been used to prevent UTIs for decades, although it is not clear how they might help protect against infection. According to one theory, ...
Clinical trials: Around half of new treatments perform better than existing treatments
2012-10-17
On average, new treatments perform better in clinical trials only slightly more often than existing treatments, according to a new systematic review published in The Cochrane Library. The fact that experimental treatments are not more effective may seem disappointing, but the authors of the review say their findings satisfy an important ethical requirement for clinical trials.
Randomised trials compare the effects of one treatment to another. In a randomised trial patients are randomly allocated to different treatment groups to ensure that like will be compared with like. ...
Common medical screen predicts liver cancer risk in general population
2012-10-17
HOUSTON — Enzyme levels in the blood routinely monitored by physicians as liver function indicators are also the best predictor of liver cancer risk for the general population, a team of scientists in Taiwan and The University of Texas MD Anderson Cancer Center reports today in the Journal of the National Cancer Institutet.
"These two enzymes alone predicted 91 percent of liver cancer cases in our prospective study," said paper senior author Xifeng Wu, M.D., Ph.D., professor and chair of MD Anderson's Department of Epidemiology. "If our research is confirmed in other ...
Pluto's moons and possible rings may be hazards to New Horizons spacecraft
2012-10-17
NASA's New Horizons spacecraft is now almost seven years into its 9.5-year journey across the solar system to explore Pluto and its system of moons. Just over two years from now, in January 2015, New Horizons will begin encounter operations, which will culminate in a close approach to Pluto on July 14, 2015, and the first-ever exploration of a planet in the Kuiper Belt.
As New Horizons has traveled through the solar system, its science team has become increasingly aware of the possibility that dangerous debris may be orbiting in the Pluto system, putting NASA's New Horizons ...
Vitamin D supplements may benefit lupus patients
2012-10-17
A new clinical study published in BioMedCentral's open access journal Arthritis Research and Therapy provides preliminary evidence that vitamin D supplementation could be considered an immunomodulatory agent for systemic lupus erythematosus (SLE), a debilitating autoimmune disease characterized not only by skin, joint, neurological and renal symptoms, but also by inflammation of tissue linings in the body.
SLE is a T- and B-cell-dependent disease that causes an appearance of autoantibodies, causing the body to attack itself. Patients present with a depletion of regulatory ...
Muscle relaxants linked with increased risk of breathing problems after surgery
2012-10-17
Muscle relaxants given to millions of patients during general anaesthesia are associated with an increased risk of serious breathing problems after surgery, finds a study published on bmj.com today.
The results also suggest that giving drugs to reverse the muscle relaxants after surgery may increase the risk further.
But an accompanying editorial argues that, in modern medicine, general anaesthesia is an extremely safe procedure and it would be a mistake to change clinical practice on the basis of this one study, however large and well executed.
Known as intermediate ...
Drugs used to immobilize patients during surgery raise risk of respiratory complications
2012-10-17
Massachusetts General Hospital (MGH) researchers have found that medications currently used to immobilize patients during surgery can increase the risk of postoperative respiratory complications. Their study being published online in the journal BMJ also found that the agent most commonly used to reverse the action of the immobilizing drug does not prevent and may possibly increase the risk that patients will need to receive postoperative respiratory support.
"Neuromuscular blocking agents are used during surgery for a variety of reasons, including allowing placement ...
Many options available to help smokers kick the habit
2012-10-17
Smokers who have tried to quit and failed may be tempted to just give up, particularly if they hear statistics like the fact that most quit attempts will be unsuccessful. But smokers today have many options to help them quit, and those who think they have "tried it all" usually have not. In a report in the Oct. 17 issue of JAMA, Nancy Rigotti, MD, director of the Tobacco Research and Treatment Center of the Massachusetts General Hospital (MGH) Department of Medicine, outlines currently available resources and recommends strategies that can help smokers who are struggling ...
New HIV prevention technology shows promise
2012-10-17
ARLINGTON, VA -- CONRAD researchers, in collaboration with engineers at the University of Utah, have designed a 90-day intravaginal ring that can be used by women to prevent the sexual transmission of HIV. A study of the ring used sheep to determine whether safe, effective and steady doses of the antiretroviral drug tenofovir can be released over 90 days. This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in Chicago, Ill., Oct. 14 – 18 and will be published in the 12th issue of Antimicrobial ...
New study aims to predict risk of cancer
2012-10-17
New research at the University of Southampton aims to develop a way of predicting who is more at risk of getting cancer.
Led by Paul Little, Professor of Primary Care Research, the CANcer DIagnosis Decision rules (CANDID) study, funded by the National Institute for Health Research (NIHR) School for Primary Care Research (NIHR SPCR), will collect and analyse clinical information and blood samples from 20,000 patients who have had lung or colon cancer. The aim is to determine which signs and symptoms are most predictive of those who go on to be diagnosed with the disease. ...